All Type of News
KFDA operating Resolution Center for BT Products
The KFDA announced to set up "Resolution Center for BT Products" in the National Institute of Toxicological Research on May 30 in order to resolve any difficulties for researchers or bio venture companies related to t...
Overall NHI reimbursement standards to reshuffle.
The MOHW announced the NHI reimbursement review on 67 subjects at the 1st step after modifying overall NIH reimbursement standards in terms of the national health insurance system improvement.
The MOHW's task forc...
Drug wholesalers to raise credibility of IMS data.
The Korea Pharmaceutical Wholesaler Association (KPWA) pointed our quite remarkable statistic errors of the IMS data on the weight of drug distribution in Korea, which was probably attributed to the extrapolate interp...
Drug makers and wholesalers in conflict on unified distribution system.
The pharmaceutical manufacturers and wholesalers have confronted each other over the issue on the unified drug distribution system, for which the manufacturers claimed to scrap while the wholesalers resisted.
The d...
KFDA to reshuffle its organization.
The KFDA transformed its organization in which the drug division span off the existing 4 into 7 subdivisions including the Drug Information Team and Clinical Administration Team, mainly targeting to reinforce 3 areas ...
Il Yang to appoint new directors of board.
In the general shareholders meeting on May 27 Il Yang determined dividends by 4% for common stocks and 5% for preferred stocks.
President Yoo Tae-sook said "The 34th fiscal year of Il Yang had made a ground for the...
Dongwha achieved targets of productivity, cost saving and profits.
Dongwha decided 10% cash dividends in the 76th general shareholders meeting at Ahnyang plant at 10 a.m. on May 27.
President Yoon said "Given difficult circumstances inside and outside Korea, we have achieved 12.2%...
Drug wholesalers in backlash to Green Cross's margin policy.
On May 27 Green Cross responded to the official letter earlier questioned by The Korea Pharmaceutical Wholesaler Association (KPWA) over the issue of distribution margins, covering the terms and conditions the KPWA h...
KPMA to urge scrap of unified drug distribution system.
The Korea Pharmaceutical Manufacturers Association (KPMA) recommended to the Cheongwadae, the office of the president, the office for the government policy coordination, the MOHW, the KFDA and the Fair Trade Commissio...
75% of Korean asthma patients on poor controls.
3 in 4 Korean asthma patients believed that the disease be well treated but only 20% of them were controlled well according to the recent survey conducted by the Korea Asthma Allergy Association.
The survey on 300 ...
